reactive lymph node lesions, including, increasingly, lymphadenopathy associated with AIDS78 and occasionally Hodgkin's disease. 9 Despite thorough investigations of the lineage links between monocytoid B cells and other cell subsets, the exact position of monocytoid B cells in the B cell system is still unknown.?'1016
The first malignant lymphoma composed of monotypic monocytoid B cells was described by McGinn et al in 1985 . '7 To date 56 cases of monocytoid B cell lymphoma (MBCL) have been documented.7126 MBCL has been compared with other low grade lymphomas from a morphological, immunological, and clinical point of view. 9 17-2022252728 Though compatible with hairy cell leukaemia (HCL) in many aspects,2 27 MBCL has been established as a novel B cell neoplasm with a well defined morphological pattern and a distinct phenotype. Due to its extreme rarity few clinical data are available. 232528 The objective of the present study was to evaluate diagnostic, clinical, and especially prognostic features of patients with monocytoid B cell lymphoma.
Methods
Twenty one cases of nodal MBCL were drawn from the files of the Lymph Node Registry in Kiel (table 1) . In seven cases an additional lymphoma was documented in the stomach (n = 4), nasopharynx (n = 1), salivary glands (n = 1), or thyroid gland (n = 1) (table 2). The histological sections were re-examined. They had been fixed in 5- 10% formaldehyde, embedded in paraffin wax, and routinely stained with Giemsa, haematoxylin and eosin, periodic acid Schiff and Gomori's silver impregnation. Additionally, the sections were dewaxed, rehydrated, digested in trypsin and immunostained using the peroxidase-antiperoxidase method. 29 Follow up of 18 patients provided prognostic data (table 3) . Three of the patients could not be evaluated in terms of survival because the diagnosis was too recent. Clinical information was acquired from questionnaires and clinical reports provided by clinicians and general practitioners. Actuarial survival was calculated by the life table method of Kaplan and Meier.0 Cogliatti, Lennert, Hansmann, Zwingers When they were localised in the stomach or nasopharynx (fig 4) , the extra-nodal manifestations that were combined with nodal MBCL in seven patients showed the characteristic features of a low grade B cell lymphoma of the mucosa-associated lymphoid tissue (MALT) including lymphoepithelial lesions (n = 4) and reactive intratumoural germinal centres (n = 4). One case, however, had developed into a centroblastic polymorphic lymphoma in the stomach and one into an unclassified high grade lymphoma in the salivary glands.
Of a total of 21 patients, aged 34 to 83 years, 11 were male and 10 female. The age distribution curve showed peaks in the 6th and 8th decades (fig 5) .
HISTORY BEFORE DIAGNOSIS AND INITIAL SYMPTOMS
In 17 patients the initial symptoms were peripheral lymphadenopathy, localised at one site (n = 9), two sites (n = 2), or generalised ; * (n = 6), lasting for between one month to two years. In one case a previous biopsy specimen of submandibular soft tissue had shown an ' undefinable lymphoid infiltration, and in another a previous submandibular swelling , had shown spontaneous regression.
: Additional symptoms were flu-like episodes in / two cases and swelling of the ipsilateral buttock in one case of inguinal lymphadenopathy. Three other patients with paragastric MBCL > associated with gastric lymphoma had a hisg tory of persistent ulcers for one to four years. g Finally, in one patient a history of progressing A, goitre over a period of four years and an i earlier occurrence of Hashimoto's disease preceded an asymptomatic lymphoma in the g thyroid combined with MBCL in a regional g lymph node, both unexpectedly discovered in the thyroidectomy specimen. Seven patients with MBCL initially had B ular symptoms. Fever was reported in three patients, night sweating in four, itching in one, and alcohol intolerance in two as well as weight loss in one patient with an additional gastric lymphoma.
ASSOCIATED DISEASES AND PREVIOUS AILMENTS
Nine patients also had minor or major cars diovascular disease. One patient presented with atopic trias and porphyria cutanea tarda due to liver cirrhosis and carcinoma, another with ethylic liver disease, and one with chronic persistent hepatitis. One patient had . had benign colon polyps, three had tuberculosis, one had mononucleosis, and one had Six (28%) patients were in stage IV. They had hepatosplenomegaly (n = 4), splenomegaly (n = 1), or hepatomegaly (n = 1) combined with generalised (n = 5) or localised (n = 1) lymphadenopathy. Pathological staging was performed in four patients with positive biopsy specimens of bone marrow (n = 2), liver (n = 1), or both (n = 1). In another patient spleen and liver disease were first confirmed during post mortem examination. In one case MBCL was combined with a lymphoma in the stomach and in one with a lymphoma in the salivary glands.
Treatment protocols for each case varied widely, irrespective of the stage of disease.
Diagnostic lymph node excision (n = 2) or complete removal of affected nodal and extranodal tissue (n = 3) was the only treatment given to three patients in stage I and two patients in stage IIE Three patients in stage I were treated with radiotherapy alone; two patients in stage IIE had radiotherapy postoperatively, and one patient in stage IIIs was treated with a combination of radiotherapy and chemotherapy. Different forms of radiotherapy were applied: involved field radiation (IFR) (n = 2), extended field radiation (ERF) (n = 2), or abdominal radiation (n = 2) with a dose ranging from 30 to 45 Gy.
Chemotherapy 14 with manifest lymphoma in the thyroid and a regional lymph node, after strumectomy and EFR (45 Gy). Case 1, who had cervical and supraclavicular lymphadenopathy associated with nasopharyngeal lymphoma, experienced a local relapse four months after removal of the tumour and neck dissection. In spite of repeated surgery and radiotherapy the patient died 54 months after diagnosis in an unknown condition. Case 9, with gastric and paragastric disease, underwent gastrectomy. Local and para-aortal relapse after 22 months was treated with chemotherapy (COP) and abdominal radiation, and no further lymphoma was found.
The two patients in clinical stage IIIs were both brought into complete remission and both were followed up. Case 8 was treated with chemotherapy (CHOP) and abdominal radiation (30 Gy). After 23 months of complete remission a relapse occurred in the supradiaphragmatic lymph nodes accompanied by pleural effusion. Further chemotherapy (COP-BLAM) resulted in only partial remission. Case 7, treated with chemotherapy (COP and ABV), had a relapse in cervical and axillary lymph nodes after 36 months of complete remission and was undergoing renewed chemotherapy (ABVD) at the completion of this study.
Five of the patients in stage IV were followed up and two of them went into complete remission. Case 12, who showed a coincidental gastric lymphoma and transformation into a centroblastic polymorphic lymphoma at gastric and paragastric sites, underwent gastrectomy and primary chemotherapy (CHOP). A generalised relapse occurred after one month of complete remission and the patient died before renewed radiotherapy had been fully administered, 15 months after diagnosis. In case 13 chemotherapy (COP) resulted in complete remission for 10 months, when an additional unclassified high grade lymphoma was discovered in bilateral salivary glands, just at the completion of this study. Three patients only were brought into partial remission: case 15 after 10 cycles of KNOSPE and cases 11 and 16, who were treated with continuous Leukeran or Decortin chemotherapy. Case 16 was still undergoing treatment at the completion of our study, but case 11 had died three months after diagnosis.
PROGNOSIS
Eighteen patients with MBCL were followed up for three to 83 months (mean follow up period 34 months). With treatment 15 patients were brought into complete remission for periods ranging from one to 78 months (mean 28 months). Six patients, all in early stages, stayed free of relapse (maximum 78 months). Nine (5000) patients, however, relapsed after complete remissions lasting from one to 55 months (mean 20 months). Four were in an early stage and five in an advanced stage. In case 5 this was only discovered at necropsy. Only three patients managed to go into partial remission.
Five patients died within three to 54 months after diagnosis. Two of them were in an early stage and three in an advanced stage at diag- When this study had been completed eight patients were in complete remission, two in partial remission, and three were undergoing treatment.
Overall, the probability of survival for the whole group after 83 months was lower than that for a comparable normal population. The survival curve showed a constant downward slope with no plateau (fig 7) , comparable with the progression seen in other low grade lymphomas.
Discussion
Twenty one patients with MBCL were studied and 18 of them evaluated for prognostic features. Special emphasis was placed on seven cases in which the nodal MBCL occurred in combination with a lymphoma in the stomach (n = 4), nasopharynx (n = 1), salivary glands (n = 1), or thyroid gland (n = 1).
Our morphological and immunological findings were compatible with those of previous studies9 and will be published in a separate paper. The observation that monoclonality was evident only in plasma cells in two cases with pronounced plasmacytic differentiation, while monocytoid B cells did not express any immunoglobulin at all, is worth mentioning for its diagnostic implications.
We In seven patients with nodal MBCL a low grade B cell lymphoma of the MALT was found-in four ofthem this was in the stomach, in one in the nasopharynx, in one in the salivary glands and in one in the thyroid gland, which possibly belongs to the MALT. In two cases the tumour had developed into a high grade lymphoma. This coincidence merits more thorough discussion. Except for one case, MBCL was diagnosed in the corresponding regional lymph nodes so the question arises whether MBCL represents the equivalent in the lymph node of a low grade B cell lymphoma of the MALT. Morphological and immunological evidence may support this presumption when we compare these two lymphomas.
MBCL was characterised by its typical growth pattern of broad strands, by reactive looking germinal centres, and increased venules within the tumour infiltrates. Cytologically, the medium sized monocytoid B cells mainly showed irregularly shaped nuclei and a fairly broad rim of slightly basophilic cytoplasm. They (n = 3), the breast (n = 2), the perigastric space with spread to the liver (n = 1), the tonsil (n = 1), and the retroperitoneal space (n = 1 
